Happy weekend everyone. Going to make a more detailed tip next week about PAA. Several board changes which have tanked the sp by nearly 50%. Big announcement today with fda approval of the ODD.
No changes to the progress of the company though. It is trading at levels near Jan 2024, back when it fda approval of the odd wasn't granted. A lot of selling and accumulation today, but I suspect this is a shakedown. Once phase 2 and 3 trials kick off in H2 2024 I can see this being pushed up back to high 30s.
